Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Hugh Auchincloss, pleural mesothelioma robotic surgeon

Dr. Hugh G. Auchincloss

Thoracic Surgeon

Dr. Hugh G. Auchincloss at Massachusetts General Hospital is a thoracic surgeon who utilizes robotic procedures and minimally invasive techniques to treat a wide range of chest disorders.

Get in touch
Jump to a Topic:

About Hugh G. Auchincloss

  • Pleural and Lung Cancer icon

    Pleural Mesothelioma

  • Robotic Surgery icon

    Robotic Surgery

  • Board Certified icon

    Board Certified in Thoracic Surgery

  • Minimally Invasive Surgery icon

    Minimally Invasive Surgery

Auchincloss has developed a special interest in treating patients with lung and pleural diseases such as malignant mesothelioma.

He joined the Massachusetts General Hospital (MGH) Division of Thoracic Surgery in 2018, following in the footsteps of his father, Hugh Auchincloss Jr.

Auchincloss Jr., an international pioneer in the field of organ transplantation, operated a laboratory in transplantation immunology. He later served as the principal deputy director of the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health.

His son became a third-generation surgeon, establishing his own niche today with robotics and a minimally invasive approach to treating patients.

The benefits are a quicker post-surgery recovery, less postoperative pain and blood loss, shorter hospital stays, and a return to normal activities for the patients he serves.

Robotic surgery, which involves tiny instruments controlled remotely by a surgeon at a computer board, is used more extensively with lung cancer. With mesothelioma, it is more of a diagnostic tool.

The thoracic surgery program at MGH is part of a multidisciplinary team that designs an individualized plan for each patient it sees. The program is one of the most experienced in the world today at treating lung cancer with genetic mutations.

Clinical Interests Are Broad

His clinical interests also include esophageal cancer, gastroesophageal reflux disease, achalasia, thymoma, tumors of the mediastinum and the surgical treatment of myasthenia gravis.

Auchincloss graduated from Harvard Medical School, where his father once taught, in 2008. He completed his training in cardiothoracic surgery and general surgery at MGH.

He is a member of the American College of Surgeons, the General Thoracic Surgery Club and the Society of Thoracic Surgeons.

His work has been published in Journal of Thoracic Diseases, Annals of Thoracic Surgery, Shields’ General Thoracic Surgery 8th edition and Current Surgical Therapy.

See More Top Mesothelioma Doctors

Disclaimer: Dr. Hugh G. Auchincloss has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Matt Mauney, Content Writer at
Edited by

2 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Massachusetts General Hospital. (n.d.). Hugh G. Auchincloss biography.
    Retrieved from:
  2. National Institutes of Health. (2006, February 6). NIAID Announces Senior Management Appointments. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified December 5, 2019

Get Your Free Mesothelioma Guide Chat live with a patient advocate now